Products and services hormone replacement therapy
Sometime between the age 45 and 55, women experience a period of change called the menopause, when production of the hormones oestrogen and progesterone gradually ceases. Many women experience uncomfortable symptoms from the menopause, such as hot flushes, night sweats and insomnia. After the menopause, women also become more vulnerable to cardiovascular disease and osteoporosis as the amount of oestrogen their bodies produce decreases.
Novo Nordisk is one of the world's largest manufacturers of hormone replacement products. Our portfolio includes:
- Activelle® - a low-dose oral continuous combined HRT for postmenopausal women.
- Kliogest® - an oral continuous combined HRT for postmenopausal women.
- Trisequens® - an oral sequential combined HRT for perimenopausal women.
- Estrofem® - an oestrogen-only therapy for women who have undergone a hysterectomy.
- Vagifem® - a local HRT for intra-vaginal treatment of vaginal dryness.
